FDA Approves Antiemetic Drug for New Line of Prefilled Generic Injectables

Get Permission

BD Rx Inc, announced that the FDA has approved metoclopramide hydrochloride, an injectable antiemetic, as the second drug to be offered in the recently launched BD Simplist line of ready-to-administer prefilled generic injectables.

BD Simplist prefilled injectables are designed to help improve patient care and safety by decreasing the number of steps in the traditional vial and syringe injection sequence to approximately 12 steps, reducing the potential risk of medication error.

Metoclopramide hydrochloride is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stress, prophylaxis of vomiting associated with emetogenic cancer chemotherapy, and the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable. ■




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.